XML 60 R48.htm IDEA: XBRL DOCUMENT v3.26.1
Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued compensation $ 13,424 $ 32,179
Accrued clinical and other research & development costs 19,871 22,283
Accrued manufacturing costs 10,659 5,336
Operating lease liability, current 10,084 9,463
Finance lease liability, current 97 83
Deferred research and development funding liability, current 19,975 21,101
Other accrued costs and current liabilities 4,166 7,401
Total accrued expenses and other current liabilities $ 78,276 $ 97,846